SYSTEMS AND METHODS FOR IN-VIVO DETECTION OF LEAD IN BONE
20170245819 · 2017-08-31
Inventors
Cpc classification
A61B6/4291
HUMAN NECESSITIES
A61B6/4429
HUMAN NECESSITIES
A61B6/4258
HUMAN NECESSITIES
A61B6/5217
HUMAN NECESSITIES
G16H50/30
PHYSICS
A61B6/4476
HUMAN NECESSITIES
A61B6/4241
HUMAN NECESSITIES
International classification
Abstract
A system and corresponding method for detecting one or more high-atomic-number elements in a patient includes a Bremsstrahlung x-ray source that produces x-rays in an energy spectrum including an energy of at least 160 kiloelectron-volts (keV), a filter configured to absorb the x-rays in a region of the energy spectrum, and a collimator configured to receive the x-rays and output a collimated x-ray beam to be incident on a patient. The system and method can also include one or more collimated, energy-resolving x-ray detectors to detect fluorescent radiation emitted from the one or more high-atomic-number elements in the patient in response to the collimated x-ray beam incident on the patient. An alternative x-ray source can include a radioactive isotope. Scanning of the x-ray beam may also be performed. Embodiments enable practical clinical, in vivo measurements of lead in bone.
Claims
1. A system for detecting one or more high-atomic-number elements in a patient, the system comprising: a Bremsstrahlung x-ray source configured to produce x-rays in an energy spectrum including an energy of at least 160 keV; a filter configured to absorb the x-rays from the x-ray source in a region of the energy spectrum; a collimator configured to receive the x-rays from the x-ray source and to output a collimated x-ray beam to be incident on a patient; and one or more collimated, energy-resolving x-ray detectors configured to detect fluorescent radiation emitted from one or more high-atomic-number elements in the patient in response to the collimated x-ray beam incident on the patient.
2. The system of claim 1, further comprising a scanner configured to cause relative motion between the patient and the x-ray beam incident on the patient in order to scan at least a portion of the patient with the x-ray beam.
3. The system of claim 2, wherein the scanner is configured to move the patient with respect to the x-ray beam to cause the relative motion.
4. The system of claim 2, wherein the scanner is further configured to cause relative one-dimensional motion between the patient and the x-ray beam to scan the portion of the patient along one dimension.
5. The system of claim 2, wherein the scanner is further configured to cause relative two-dimensional motion between the patient and the x-ray beam to scan the portion of the patient along two dimensions.
6. The system of claim 1, further comprising an analyzer configured to receive signals from the one or more detectors, the signals representative of the fluorescent radiation emitted and detected, wherein the analyzer is further configured to process the signals to determine a content of the one or more high-atomic-number elements in the patient.
7. The system of claim 6, wherein the analyzer is further configured to determine the content of the one or more high-atomic-number elements with concentration as low as 5 parts per million (ppm).
8. The system of claim 1, wherein the filter is further configured to absorb the x-rays from the x-ray source in a region of the energy spectrum corresponding to x-rays Compton scattered from the patient in response to the collimated x-ray beam incident on the patient, such that a signal-to-background ratio can be enhanced.
9. The system of claim 1, wherein the filter comprises a material with an atomic number of at least 50.
10. The system of claim 9, wherein the filter further comprises a material with an atomic number in a range of about 72-92.
11. The system of claim 1, wherein the filter has a thickness of at least 0.5 mm.
12. The system of claim 1, wherein the one or more high-atomic-number elements include lead.
13. The system of claim 1, wherein the collimated x-ray beam is a pencil beam.
14. The system of claim 13, wherein the one or more collimated detectors are arranged to detect the fluorescent radiation emitted only from a path of the pencil beam in the patient.
15. The system of claim 1, wherein the collimated x-ray beam is a fan beam.
16. The system of claim 15, wherein the one or more collimated detectors are arranged to detect the fluorescent radiation emitted only from a path of the fan beam in the patient.
17. A method for detecting one or more high-atomic-number elements in a patient, the method comprising: producing Bremsstrahlung x-rays in an energy spectrum including an energy of at least 160 keV; filtering to absorb the x-rays from the x-ray source in a region of the energy spectrum; collimating the x-rays from the x-ray source to produce a collimated x-ray beam to be incident on a patient; and detecting energy-resolved, fluorescent radiation emitted from one or more high-atomic-number elements in the patient in response to the collimated x-ray beam incident on the patient.
18.-33. (canceled)
34. A system for detecting one or more high-atomic-number elements in a patient, the system comprising: an x-ray source configured to produce x-rays; a collimator configured to receive the x-rays from the x-ray source and to output a collimated x-ray beam to be incident on a patient; a scanner configured to cause relative motion between the patient and the x-ray beam incident on the patient in order to scan at least a portion of the patient with the x-ray beam; and one or more collimated, energy-resolving x-ray detectors configured to detect fluorescent radiation emitted from one or more high-atomic-number elements in the patient in response to the collimated x-ray beam incident on the patient.
35. The system of claim 34, wherein the scanner is configured to move the patient with respect to the x-ray beam to cause the relative motion.
36. The system of claim 34, wherein the scanner is configured to translate the x-ray beam with respect to the patient.
37. The system of claim 34, wherein the scanner is further configured to cause relative one-dimensional motion between the patient and the x-ray beam to scan the portion of the patient along one dimension.
38. The system of claim 34, wherein the scanner is further configured to cause relative two-dimensional motion between the patient and the x-ray beam to scan the portion of the patient along two dimensions.
39. The system of claim 34, wherein the x-ray source is a radioactive isotope.
40. The system of claim 34, wherein the x-ray source is an x-ray tube.
41. The system of claim 34, further comprising an analyzer configured to receive signals from the one or more detectors, the signals representative of the fluorescent radiation emitted and detected, wherein the analyzer is further configured to process the signals to determine a content of the one or more high-atomic-number elements in the patient.
42. The system of claim 41, wherein the analyzer is further configured to determine the content of the one or more high-atomic-number elements with concentration as low as 5 parts per million (ppm).
43. The system of claim 34, wherein the one or more high-atomic-number elements include lead.
44.-54. (canceled)
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0033] The foregoing will be apparent from the following more particular description of example embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating embodiments of the present invention.
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
DETAILED DESCRIPTION
[0046] A description of example embodiments of the invention follows.
[0047] The intensity of 88 keV gamma rays from a Curie of Cd.sup.109 is a very weak source for stimulating fluorescence from lead when compared to even a small x-ray tube. Compared to the intensity of the 88 keV gamma rays from a one Curie source of Cd.sup.109, each watt of beam power from a 200 keV x-ray tube produces about 100 times more x-rays above 90 keV. At 100 Watts, a compact x-ray tube produces approximately 100 thousand times the intensity of the 0.1 Ci sources now used for XRF-PbB. This basic fact makes practical the use of strong absorbers to shape the spectrum from a commercially available x-ray tube to obtain the necessary sensitivity in a desired short measurement time for clinical use. And it further allows different detector modalities that reduce the radiation dose burden of an in vivo examination.
Shaping the Bremsstrahlung Spectrum:
[0048] The region from 90 keV to 130 keV contains about 14% of the Bremsstrahlung spectrum for an x-ray tube operating at 200 kV. The K-shell photoelectric (PE) cross section for Pb is 10 cm.sup.2/g at the K binding energy of 88 keV and diminishes approximately as the cube of the fluorescing energy. At 120 keV, the PE cross section has dropped to 3 cm.sup.2/g and at 200 keV it is only 0.8 cm.sup.2/g. It is therefore natural to assume that the fluorescing spectrum of the primary beam should be maximized in the 88 keV-130 keV energy region to make use of the highest photo-electric cross section to excite the lead atoms, and to consequently maximize the fluorescence signal coming from the lead. In fact, when the goal is to measure sensitivities in the 5 ppm region, the opposite is true. This is a non-obvious and unexpected result, and the key to understanding this is the following: If x-rays in the energy range of approximately 88 keV-130 keV region in the primary beam undergo just a single Compton scatter event (which has a large probability of occurring), then they will be down-shifted in energy just enough to lie directly under the lead fluorescence peaks in the 72 keV-85 keV region. This creates a large background under the lead peaks, reducing the Signal-to-Noise Ratio (SNR) and reducing the sensitivity of the system.
[0049] Suppressing the incident flux in that incident region of approximately 88 keV to 130 keV of the primary beam sharply reduces the total probability for the K-shell excitation of lead, but the loss in signal is more than compensated for by relying on x-rays above 130 keV to excite the lead K-shell x-rays. This is because x-rays in the primary beam above 130 keV must be Compton scattered at least twice before being detected if they are to lie under the lead fluorescence peaks and contribute to the background, interfering with fluorescence to be detected. Since the probability of a double Compton scatter event is much lower than the probability of a single Compton scatter event, the background under the lead signal peaks is much smaller. Even though the lead excitation is also considerably lower, the overall SNR for detecting the lead in low concentrations is greatly improved.
[0050] Shaping the input spectrum can be done in a variety of ways. Filters made of Tungsten (W) are: effective, as are the higher atomic number rare earths, e.g. Erbium. Even Pb can be used if precautions are taken to keep its fluorescence K x-rays out of the targeted incident Bremsstrahlung spectrum or out of the detector itself. And combinations of different atomic number can be used to suppress the radiation fluoresced from the filters.
[0051] The results of simulations with tungsten absorbers are illustrated in
[0052] The filtration has dramatically shaped the Bremsstrahlung beam (an x-ray beam produced by a Bremsstrahlung radiative process) in
[0053] Table 1 shows the percentages in the region from 90 keV to 130 keV compared to the percentages in the region from 130 keV to 200 keV as the tungsten filter increases in thickness. One mm of tungsten has created a Bremsstrahlung beam that is dominated by the high energy region above 130 keV, with a much diminished intensity in the 90 keV to 130 keV region.
TABLE-US-00001 TABLE 1 Quantitative Values for the Spectral Changes of Tungsten Filters as shown in FIGS. 3 and 4A-4C. Tungsten Filter 0 mm 0.5 mm 0.7 mm 1 mm 90-130 keV 14% .sup. 12% 8.4% 4.9% 130-200 keV 6% 55.9% 69.9% 83%
[0054] A second action in shaping the beam profile can include using a high enough operating voltage on the x-ray tube to acquire the needed intensity of x-rays in the region above 130 keV. The higher the voltage of the x-ray tube, the lower will be the needed beam power to obtain the same sensitivity, and the smaller will be the skin entrance dose.
[0055]
[0056] In practice, the choice of high voltage will be dictated by the holistic design. In particular, the desired sensitivity of the XRF-XPbB instrument will be an important consideration. For example, a 160 keV x-ray tube, with its limited flux in the 130 keV-160 keV region, may be useful for a survey to find levels of lead poisoning above 15 ppm. For evaluations that are sensitive at the 5 ppm level, however, the minimum x-ray energy output from a tube is probably 180 keV, and high voltages that result in photon energies well above 200 keV are preferred.
Reducing the Radiological Burden by Scanning an Area of the Tibia.
[0057] The tibia is one of the longest bones in the body and typically has one of the thinnest of overlaying tissue. Even school age children have tibias that present at least 20 cm.sup.2 of area with an overlaying thickness sufficiently uniform to be useful. Herein are disclosed two distinct overall embodiments to decrease the radiation burden to any given tissue region by increasing the mass being inspected by XRF-XPbB.
[0058]
[0059] In a first embodiment, referring to
[0060] In a second embodiment, referring to
[0061] In the embodiment shown in
[0062] In the embodiment shown in
[0063] The detector module consists of a pair of collimated detectors, such as CdTe or germanium, each with its own signal processor. The example system of source and detectors, as a single unit, scans a 10 mm wide by 20 cm long area at a rate of 1 mm/sec, with a total measurement time of 200 seconds.
[0064] In one preferred embodiment, a system consistent with has the following specifications: [0065] 1. A 500 Watt Bremsstrahlung x-ray source, with a tungsten transmission anode, operating at 225 kV operating voltage. [0066] 2. A beam filter, made of material with a K electron binding energy in the range of 60 keV to 70 keV, intercepts the beam to preferentially absorb out the 90 to 130 keV Bremsstrahlung radiation. [0067] 3. A collimator of the Bremsstrahlung radiation that produces a shaped beam at the tibia. [0068] 4. The Bremsstrahlung beam enters the tibia at an acute angle of less than 35°. [0069] 5. A detector array of efficient, high resolution, high count rate detectors, such as CdTe, each with its own signal processor. [0070] 6. The detector elements of the array are highly collimated so that they can only detect single Compton scatter events or fluorescent radiation emanating from the beam path in the tibia. [0071] 7. The detector array preferentially accepts only the x-rays that have fluoresced in the forward direction. [0072] 8. The detector array has a solid angle acceptance of at least a steradian. [0073] 9. The multiple array strips and x-ray tube are fixed together as a single inspection unit. [0074] 10. The single unit scans a 1 cm wide by 20 cm long area of the tibia in approximately 200 seconds, dwelling approximately 6 seconds and 25 seconds on a given point for the embodiments of
[0075]
[0076] The system 900 includes a Bremsstrahlung x-ray source 960. A typical example Bremsstrahlung x-ray source includes an x-ray tube. An example of a Bremsstrahlung radiation energy spectrum is provided in
[0077] The system 900 also includes a filter 940 that is configured to absorb x-rays from the source 960 in a particular region of the energy spectrum output from the source. This particular region over which the filter 940 absorbs x-rays can be in an energy range of approximately 88-130 keV, for example, as described hereinabove. Examples of filtered, attenuated Bremsstrahlung radiation energy spectra are shown in
[0078] In some embodiments, this absorption range of the filter corresponds to an energy region where there is an increased cross section for producing x-ray fluorescence. The filter 940 may include any of the material thicknesses, compositions, element atomic numbers, and other specifications described herein for various embodiments.
[0079] The system 900 also includes a collimator 920 that is configured to constrict divergence of the x-ray beam 902 to produce a beam 904 that is, at least in part, collimated. As described hereinabove, a collimated beam may be partially collimated, while having greater divergence in another cross-sectional dimension, such as is in the case of a fan beam. In other embodiments, the collimated beam 904 may be a pencil beam and may be either highly collimated into dimensions or partially collimated in two dimensions.
[0080] The system 900 also includes one or more detectors 960. These detectors can include detector materials and configurations as described herein in connection with any embodiment. The one or more detectors 960 are collimated, energy-resolving x-ray detectors that are configured to detect fluorescent radiation 914 emitted from one or more high-atomic-number elements 908 in the patient.
[0081] The fluorescent radiation 914 is emitted from the element 908 in response to the collimated beam 904 that is incident on the patient 906. In one example, the fluorescent radiation 914 can include K alpha 1, K alpha 2, and K beta 1,3 x-ray fluorescence radiation from lead, as illustrated in the spectrum shown in
[0082] Also illustrated in
[0083] Furthermore, as described hereinabove, and as described in connection particularly with
[0084]
[0085] The system 1000 also includes a scanner 1018 that is configured to translate the patient 906, or a portion of the patient, such as a leg, with respect to the collimated beam 1004, with example scan motion 1020, in order to scan at least a portion of the patient 906 with the collimated x-ray beam 1004. The scan motion 1020 may be in one dimension or two dimensions, for example. Furthermore, the scan motion may be in three dimensions in certain embodiments.
[0086] In some embodiments, the scanner 1018 is a patient table on which the patient lays, which translates the patient with respect to the beam. However, many various actuators are known and can be configured to hold a leg of the patient 906 and translate only the leg, for example. Furthermore, it embodiments such as that shown in
[0087]
[0088] At 1126, the x-rays from the x-ray source are collimated to produce a collimated x-ray beam to be incident on a patient. At 1128, energy-resolved, fluorescent radiation emitted from the one or more high-atomic-number elements in the patient in response to the collimated x-ray beam incident on the patient is detected.
[0089] The procedure 1100 may be performed, for example, by the system 900 illustrated in
[0090]
[0091] At 1232, the x-rays from the x-ray source are collimated to produce a collimated x-ray beam to be incident on a patient. At 1234, at least a portion of the patient is scanned with the x-ray beam by causing relative motion between the patient and the x-ray beam incident on the patient. At 1236, energy resolved, fluorescent radiation is detected, where the fluorescent radiation is emitted from one or more high-atomic-number elements in the patient in response to the collimated x-ray beam incident on the patient.
[0092] In other embodiments that are similar to procedure 1200, other procedural elements may also be performed, consistent with embodiments described in the specification. In one example, a procedure similar to the procedure 1200 may also include filtering the x-ray beam from the x-ray source to attenuate at least a portion of a spectrum of x-ray energies provided by the x-ray source. Such attenuation of a portion of the spectrum is particularly helpful where the x-ray source is a broadband x-ray source, such as an x-ray tube or other Bremsstrahlung radiation source, and such attenuation can
[0093] Items within the scope of claimed and described embodiments: [0094] 1. A system designed to take an in-vivo measurement of the content of high-atomic-number elements in a patient, the system comprising: a) an x-ray tube with an operating voltage of at least 160 kV; b) a collimator to allow a beam of radiation to be incident on the patient; c) an array of one or more collimated energy resolving detectors to detect fluorescent radiation from high-atomic-number elements contained within the patient's body. [0095] 2. A system according to item 1, wherein the element being measured is lead. [0096] 3. A system according to item 1, wherein the x-ray beam is shaped with a filter consisting of a material with an atomic number of at least 50. [0097] 4. A system according to item 3, wherein the filter consists of a material with an atomic number in the range of 72-92. [0098] 5. A system according to item 4, wherein the filter is at least 0.5 mm thick. [0099] 6. A system according to item 1, wherein the collimated x-ray beam is a pencil beam [0100] 7. A system according to item 1, wherein the collimated x-ray beam is a fan beam [0101] 8. A system according to item 1, wherein the x-ray beam is raster-scanned over a two-dimensional area of the patient's body [0102] 9. A system according to item 1, wherein the x-ray beam is scanned along one dimension of the patient's body [0103] 10. A system according to item 6, wherein multiple collimated detectors are arranged to only detect radiation emanating from the path of the pencil beam in the patient's body [0104] 11. A system according to item 7, wherein multiple collimated detectors are arranged to only detect radiation emanating from the path of the fan beam in the patient's body
[0105] The following four references are hereby incorporated herein by reference in their entireties: [0106] In vivo X-ray fluorescence of lead in bone: review and current issues. A. C. Todd and D. R. Chettle. Environmental Health Perspectives, 1994 February, 102(2):172-177. [0107] Studies in Bone Lead: A New 109Cd K-XRF Measuring System. Huiling Nie, PhD Thesis, McMaster University. 2005. [0108] Application and Methodology of in-vivo K x-ray Fluoresence of Pb in Bone. Huiling Nei, Howard Hu and David R. Chettle. X-Ray Spectrometry Vol. 37, January/February 2008 [0109] Bone Lead Measured by x-ray Fluorescence: Epidemiologic Methods. Howard Hu, Antonio Aro and Andrea Rotnitzky”)
[0110] The teachings of all patents, published applications and references cited herein are incorporated by reference in their entirety.
[0111] While this invention has been particularly shown and described with references to example embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.